![]() |
- 品牌:EnkiLife
- 产地:中国
- 型号:支
- 货号:PCH90010
- 价格: ¥900/10μg
- 发布日期: 2024-11-30
- 更新日期: 2025-05-22
产地 | 中国 |
保存条件 | |
品牌 | EnkiLife |
货号 | PCH90010 |
用途 | 细胞培养用细胞因子 |
组织来源 | |
细胞形态 | |
是否是肿瘤细胞 | |
保质期 | |
器官来源 | |
免疫类型 | |
品系 | |
生长状态 | |
物种来源 | |
包装规格 | 支 |
是否进口 | 否 |
分子别名
Fibroblast growth factor 4; FGF-4; Heparin secretory-transforming protein 1; HST; HST-1; HSTF-1; Heparin-binding growth factor 4; HBGF-4; Transforming protein KS3; FGF4; HST; HSTF1; KS3
Bioactivity
The ED50 for this effect is 0.25-1 ng/mL
背景介绍
Fibroblast growth factor 4(FGF-4) is a heparin binding member of the FGF family. The human FGF4 cDNA encodes 206 amino acids (aa) with a 33 aa signal sequence and a 173 aa mature protein with an FGF homology domain that contains a heparin binding region near the C-terminus. Mature human FGF4 shares 91%, 82%, 94% and 91% aa identity with mouse, rat, canine and bovine FGF4, respectively. Human FGF-4 has been shown to exhibit cross species activity. Expression of FGF-4 and its receptors, FGF R1c, 2c, 3c and 4, is spatially and temporally regulated during embryonic development. FGF-4 is proposed to play a physiologically relevant role in human embryonic stem cell selfrenewal. It promotes stem cell proliferation, but may also aid differentiation depending on context and concentration, and is often included in embryonic stem cell media in vitro. FGF-4 is mitogenic for fibroblasts and endothelial cells in vitro and has autocrine transforming potential. It is a potent angiogenesis promoter in vivo and has been investigated as therapy for coronary artery disease.